KLF6 and bacterial infectious disease: In the murine lung infection model, CPBP NPs were preferentially accumulated in the lungs, effectively protecting the lung tissue from bacterial infection by eradicating pathogenic bacteria, suppressing ROS production, and inhibiting the expression of pro-inflammatory mediators, including TNF-α, IL-1β, and IL-6.